Friedberg Ezra M's Form 4 filing
Pelthos Therapeutics Inc. (PTHS) · filed Jul 3, 2025
- Accession no.
- 0001753926-25-001079
- Filed
- Jul 3, 2025
- Trade date
- Jul 1, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Friedberg Ezra MCIK 0001679440 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | CConversionAcquired | +40,000 | $10.00 | +$400,000 | 40,000 | Indirect | |
| Jul 1, 2025 | Common Stock | CConversionAcquired | +40,000 | $10.00 | +$400,000 | 40,000 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Common Stock | PPurchaseAcquired | +92,072 | $0.00 | $0 | 40,000 | Indirect | |
| Jul 1, 2025 | Common Stock | PPurchaseAcquired | +40,000 | $0.00 | $0 | 40,000 | Indirect | |
| Jul 1, 2025 | Common Stock | CConversionDisposed | −40,000 | $0.00 | $0 | 0 | Indirect | |
| Jul 1, 2025 | Common Stock | CConversionDisposed | −40,000 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.